Ex vivo uses of immunostimulatory combinations
US8329197B2 · kind B2 · utility
14Cited by
73References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 29, 2010 |
| Grant date | Dec 11, 2012 |
| Priority date | — |
| Expiry date | Nov 18, 2030 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides immunostimulatory combinations. Generally, the immunostimulatory combinations include a TLR agonist and a TNF/R agonist. Certain immunostimulatory combinations also may include an antigen.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.